All In MedTech

FDA Clearance Tracker · P010014-S105

Oxford™ Cementless Partial Knee System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 22, 2024

Approved

Time to decision

536 days

Received Jun 5, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P010014-S105
Device name
Oxford™ Cementless Partial Knee System
Applicant location
Warsaw, IN
Received
Jun 5, 2023
Decided
Nov 22, 2024
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010014

Device type

Device class
Class III

Every decision under product code NRA

FDA's approval statement

As written in FDA's record.

The Oxford Cementless Partial Knee System is indicated for use in unilateral knee procedures with osteoarthritis or avascular necrosis limited to the medial compartment of the knee. It is intended to be implanted without the application of bone cement for patients whose clinical condition would benefit from a shorter surgical time compared to the cemented implant.

Source documents

Other decisions for Biomet Manufacturing Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.